Author:
Zhao Di,Wang Jian,Sang Shengtian,Lin Hongfei,Wen Jiabin,Yang Chunmei
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Health Policy,Computer Science Applications
Reference35 articles.
1. Dimasi JA. Risks in new drug development: approval success rates for investigational drugs. Clin Pharmacol Ther. 2001; 69(5):297–307.
2. Morgan S, Grootendorst P, Lexchin J, Cunningham C, Greyson D. The cost of drug development: A systematic review. Health Policy. 2011; 100(1):4–17.
3. Ahmed A. Literature-based discovery: Critical analysis and future directions. Int J Comput Sci Netw Secur (IJCSNS). 2016; 16(7):11–26.
4. Gubiani D, Petrič I, Fabbretti E, Urbančič T. Mining scientific literature about ageing to support better understanding and treatment of degenerative diseases. In: Conference on Data Mining and Data Warehouses. Ljubljana: 2015.
5. Ahmed A, Alhashmi SM. A metric for literature-based discovery methodology evaluation. In: Computer Systems and Applications. Agadir: IEEE: 2016. p. 1–5.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献